USD 0.0
(0.0%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -3.43 Million USD | -24.95% |
2022 | -3.05 Million USD | -41.33% |
2021 | -6.45 Million USD | -2484.9% |
2020 | - USD | -40.42% |
2019 | - USD | 47.41% |
2018 | -76.87 Thousand USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -165.39 Thousand USD | 100.0% |
2024 Q2 | -22.78 Thousand USD | 0.0% |
2023 Q3 | -660.69 Thousand USD | -17.6% |
2023 Q2 | -561.8 Thousand USD | 3.63% |
2023 FY | - USD | -24.95% |
2023 Q1 | -582.97 Thousand USD | -14981.23% |
2023 Q4 | -757.64 Thousand USD | -14.67% |
2022 Q4 | -3865.55 USD | 99.71% |
2022 FY | - USD | -41.33% |
2022 Q3 | -1.34 Million USD | 19.69% |
2022 Q2 | -1.68 Million CAD | -3012.39% |
2022 Q1 | 57.69 Thousand CAD | 102.61% |
2021 Q2 | 164.66 Thousand CAD | 114.08% |
2021 Q1 | -1.16 Million CAD | -3305.36% |
2021 Q3 | 640.63 Thousand CAD | 289.04% |
2021 FY | - USD | -2484.9% |
2021 Q4 | -2.2 Million USD | -444.53% |
2020 Q3 | -12 Thousand CAD | 0.0% |
2020 Q1 | -14 Thousand CAD | -3.58% |
2020 FY | - USD | -40.42% |
2020 Q4 | -34.33 Thousand CAD | -186.1% |
2020 Q2 | -12 Thousand CAD | 14.29% |
2019 Q4 | -13.51 Thousand CAD | -2.28% |
2019 FY | - USD | 47.41% |
2019 Q3 | -13.21 Thousand CAD | -10.47% |
2019 Q2 | -11.96 Thousand CAD | 12.9% |
2019 Q1 | -13.73 Thousand CAD | 0.0% |
2018 FY | - USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
American Bio Medica Corporation | -1.16 Million USD | -195.347% |
Arrayit Corporation | -3.07 Million USD | -11.613% |
Atlantic International Corp. | -5.38 Million USD | 36.268% |
Biocept, Inc. | -30.24 Million USD | 88.642% |
Bioqual, Inc. | 3.03 Million USD | 213.279% |
CardioGenics Holdings Inc | -757.37 Thousand USD | -353.526% |
DermTech, Inc. | -97.89 Million USD | 96.491% |
Global WholeHealth Partners Corporation | - USD | Infinity% |
Hangzhou Tigermed Consulting Co., Ltd. | 2.91 Billion USD | 100.118% |
HTG Molecular Diagnostics, Inc. | -20.24 Million USD | 83.031% |
iMD Companies, Inc. | -154.65 Thousand USD | -2120.943% |
IDenta Corp. | 71.58 Thousand USD | 4898.202% |
Interpace Biosciences, Inc. | 3.83 Million USD | 189.52% |
Integrative Health Technologies, Inc. | 38.69 Thousand USD | 8977.976% |
InVitro International | 6680.00 USD | 51520.494% |
Lumos Diagnostics Holdings Limited | -5.43 Million USD | 36.812% |
Many Bright Ideas Technologies Inc. | -12.13 Thousand USD | -28207.969% |
Medical Imaging Corp. | -896.74 Thousand USD | -283.041% |
NovelStem International Corp. | -3.78 Million USD | 9.269% |
Optigenex Inc. | -1.18 Million USD | -189.443% |
PharmChem, Inc. | 1.05 Million USD | 425.95% |
Proteome Sciences plc | -1.13 Million USD | -202.101% |
Response Genetics, Inc | -19.66 Million USD | 82.534% |
Rennova Health, Inc. | -234.81 Thousand USD | -1362.806% |
RushNet, Inc. | -614.85 Thousand USD | -458.653% |
Stella Diagnostics Inc. | -5.7 Million USD | 39.817% |
StageZero Life Sciences Ltd. | -10.27 Million USD | 66.555% |
Todos Medical Ltd. | -9.39 Million USD | 63.435% |